Structural insights into the activation and inhibition of the ADAM17–iRhom2 complex
Open Access
- 13 June 2025
- journal article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 122 (24)
Abstract
The endopeptidase activity of ADAM (a disintegrin and metalloproteinase)-17, the primary processor of several EGFR ligands and tumor necrosis factor-alpha (TNF-α), is essential for proper embryonic development and immune regulation. Dysregulated ADAM17 activity is prevalent in a wide array of human diseases, including cancer, chronic inflammation, and SARS-CoV-2 viral progression. Initially translated as an inactive zymogen, ADAM17 maturation and enzymatic function are tightly regulated by its obligate binding partners, the inactive rhomboid proteins (iRhom) -1 and -2. Here, we present the cryo-EM structure of the ADAM17 zymogen bound to iRhom2. Our findings elucidate the interactions within the ADAM17–iRhom2 complex, the inhibitory mechanisms of the therapeutic MEDI3622 antibody and ADAM17 prodomain, and the previously unknown role of a membrane-proximal cytoplasmic reentry loop of iRhom2 involved in the mechanism of activation. Importantly, we perform cellular assays to validate our structural findings and provide further insights into the functional implications of these interactions, paving the way for developing therapeutic strategies targeting this biomedically critical enzyme complex.Keywords
All Related Versions
Funding Information
- HHS | NIH | National Institute of General Medical Sciences (R35GM146830)
- HHS | NIH | National Institute of General Medical Sciences (R35GM134907)
- HHS | NIH | National Institute of General Medical Sciences (R35GM146890)
This publication has 75 references indexed in Scilit:
- Structural basis for membrane-proximal proteolysis of substrates by ADAM10Cell, 2023
- Function and proteolytic generation of the soluble interleukin-6 receptor in health and diseaseBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2022
- The iRhom homology domain is indispensable for ADAM17-mediated TNFα and EGF receptor ligand releaseCellular and Molecular Life Sciences, 2021
- Targeted truncation of the ADAM17 cytoplasmic domain in mice results in protein destabilization and a hypomorphic phenotypeJournal of Biological Chemistry, 2021
- Novel functions of inactive rhomboid proteins in immunity and diseaseJournal of Leukocyte Biology, 2019
- Structural Basis for Regulated Proteolysis by the α-Secretase ADAM10Cell, 2017
- The shedding protease ADAM17: Physiology and pathophysiologyBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2017
- Phosphorylation of iRhom2 Controls Stimulated Proteolytic Shedding by the Metalloprotease ADAM17/TACECell Reports, 2017
- EGF Receptor Is Required for KRAS-Induced Pancreatic TumorigenesisCancer Cell, 2012
- RHBDF2 Mutations Are Associated with Tylosis, a Familial Esophageal Cancer SyndromeThe American Journal of Human Genetics, 2012